Navigation Links
Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
Date:6/29/2009

PITTSBURGH, June 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has executed a definitive agreement with Biocon Limited, a publicly traded company on the Indian stock exchanges, for an exclusive collaboration on the development, manufacturing, supply and commercialization of multiple, high value generic biologic compounds for the global marketplace. Through this partnership, Mylan and Biocon bring together highly complementary capabilities that will significantly advance their efforts to secure a leading position in the emerging generic biologics industry.

Mylan's Chairman and CEO Robert J. Coury commented: "Biocon is a first-class, highly respected organization, and I am extremely excited to be able to announce what I consider to be one of the more comprehensive and high quality biologics initiatives reported within the industry to date. After working with our Senior Vice President and Head of Global Biologics Dr. Patrick Vink and conducting extensive due diligence, I can tell you that Biocon is truly an ideal partner for Mylan."

Coury continued: "This unique collaboration combines Biocon's scientific expertise; excellent product development track record; appreciation of complex regulatory requirements; and state-of-the-art, cost-efficient and scalable biologics manufacturing with Mylan's one-of-a-kind global commercial footprint and our regulatory expertise around the world. Biocon also has a unique corporate culture that is very similar to Mylan's. All of these attributes will provide a critical synergy and create a strong and effective long-term partnership. Generic biologics, especially monoclonal antibodies, are expected to become the next great bolus of growth in the generic pharmaceutical industry, and through this alliance, Mylan and Biocon have covered all four corners of what any organizati
'/>"/>

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
2. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
3. Mylans Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments
4. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
5. Mylan Confirms Four First-to-File Challenges
6. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
7. Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
8. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
9. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
10. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
11. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotec... virus, genomic data from the 1918 pandemic throug...rrent H1N1 pandemic, today issued its latest bioch...hat the lethality of the H1N1 ("Swine Flu") virus ... the virus,s current outbreak in the spring of 200...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia...per and provider of vaccines, announced today that...ablish Sinovac (Dalian) Vaccine,Technology Co., Lt..., produce,and commercialize human-use vaccines. Si... in developing and commercializing world-class vac...
(Date:11/24/2009)... , HOUSTON, Nov. 24 /PRNewswire-FirstCall/ ...er of electrical and communications systems and se...ial markets, announced today that its commercial b...hattan Torcon JV to install the electrical systems...t facility at the U.S. Army Medical Research Insti...
(Date:11/24/2009)... , CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNe...nced today it is acquiring the assets of Hyland Se...Ontario. The addition of Hyland Seeds will further...s the company anticipates the introduction of Sma...cide Tolerant Trait Technology in corn in 2012. Th...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...Inc.,(Nasdaq: RDEA ) today announced that data wi...vestigational non-nucleoside reverse transcriptase...eficiency virus (HIV) at,the 48th Annual ICAAC/IDS...,25-28, 2008., Dr. Graeme Moyle, Director of HIV ...resent pharmacokinetic and pharmacodynamic data fr...
...eakers at IMAPS 2008 , Wa...ational Microelectronics and Packaging Society (IM...nd Dr Zolper have agreed to be the Keynote Speaker...croelectronics (IMAPS ,08) at the Providence, RI, ...MAPS ,08 is truly fortunate to have two such disti...
...to drive improvements in customer ...y 28 AMICAS, Inc. (Nasdaq: AMCS ),a leader in ra...nt,solutions, today announced a new partnership wi...nia,s most influential radiology groups., (Logo: ...ASLOGO ), For more than 40 years, Arcadia has pr...
Other Biology Technology:Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting 2Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting 3Rhode Island Governor Donald L. Carcieri and Dr. John C. Zolper, Vice President, Raytheon Company to Speak at IMAPS 2008 2Arcadia Radiology Medical Group Chooses AMICAS 2Arcadia Radiology Medical Group Chooses AMICAS 3
(Date:11/25/2009)...ad of the Cell Death Research Laboratory in the Un...n awarded the prestigious Johnson & Johnson Focuse...se of brain cell damage in Parkinson,s disease. Th...in support of innovation and excellence in science...earlier this month at an event at the Hyatt Regenc...
(Date:11/25/2009)...fetime, the heart pumps some 250 million liters of...the muscle fibers of the heart have to be extremel...ng Rottbauer, vice chair of the Department of Medi...an: Prof. Dr. H. A. Katus), has discovered a prote...allest muscular unit, the sarcomere. In cooperatio...
(Date:11/25/2009)...eat may be just as vital to your health as what yo... Biological Studies. Their experiments in mice rev...s of genes in the liverthe body,s metabolic cleari... by the body,s circadian clock as conventional wis...ctivity of a large number of genes completely inde...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Nonsurgical Treatment May Ease Rotator Cuff Injury 50382 1Nonsurgical Treatment May Ease Rotator Cuff Injury 50382 2Nebraska Prescription Assistance Program Launched 50377 1Nebraska Prescription Assistance Program Launched 50377 2Hyperion Therapeutics Raises 2460 Million Series C 50374 1Hyperion Therapeutics Raises 2460 Million Series C 50374 2Hyperion Therapeutics Raises 2460 Million Series C 50374 3
...t Reader to be the Latest Addition to M2SYS, ...TA, Aug. 14 M2SYS Technology, a biometric,technol... its partnership,with SecuGen Corporation to suppo...ter Plus. The Hamster Plus fingerprint reader fea...ally checks for the presence of a finger. The,read...
...eaches 275,000 Enrollment Milestone, NEW YORK, Au... showcase, PerSay, the leader in voice biometrics,... powers Bell,s Voice,Identification Service. Bell,...s made a spoken pass phrase the universal identifi...ts (wireline, wireless, high-speed,Internet, digit...
...ssembly of the six billion base pairs from the gen...zed genomics , Researchers at the J. Craig Venter... Hospital for Sick Children in Toronto and the Uni...shed a genome sequence of an individual, Craig Ven...e inherited from each parent. , Two other versi...
Other Biology News:M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology 2Voice Biometrics Gains Traction as Most Accurate and Convenient Technology to Secure Customer Privacy 2First individual genome sequence published 2First individual genome sequence published 3First individual genome sequence published 4
GeneSnap from SYNGENE
E. coli Protein Sample, lyophilized, 2.7 mg from Bio-Rad
DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.
...m provides excellent performance, reliability and ...ions, including washing of ELISAs, cellular assays...e, such as for PCR clean-up. The platforms outstan...r plate washers, with options including a process ...
Biology Products: